PHARMACY

HDA taps Drew, Mauch to lead board of directors
Greg Drew, president of Value Drug was elected chairman of HDA's board of directors, succeeding Jon Giacomin, who served as chairman for two years.
Eisai gets FDA nod for expanded indication of Fycompa
Eisai has received the FDA's approval for an expanded indication of Fycompa in pediatric patients age 4 years old and older who have seizures.

SilverScript unveils options to lower out-of-pocket drug costs

CVS Health's SilverScript Insurance is offering new Medicare Prescription Drug Plan options to help lower consumers' out-of-pocket prescription drug costs.
Teva is introducing generic Cialis

Teva is launching the first generic Cialis, which had a market value of about $1.93 billion for the 12 months ended July 2018, according to IQVIA data.
CVS Health recognizes its pharmacists for American Pharmacists Month

In honor of American Pharmacists Month, which takes place each October, CVS Health is recognizing its 30,000 pharmacists.
Dr. Reddy’s introduces generic Gleevec tablets

Dr. Reddy's has received the FDA okay to launch a generic version of Novartis' Gleevec, with a brand and generic market value of about $868 million.
Pfizer names Albert Bourla to succeed Ian Read as CEO

Pfizer has elected Albert Bourla as CEO, succeeding Ian Read, who will serve as executive chairman of Pfizer's board of directors, effective Jan. 1, 2019.
DSNTV: Good Neighbor Pharmacy’s Zilka talks role of independent pharmacies

Drug Store News sat down with Jennifer Zilka, group vice president of field programs and services at Good Neighbor Pharmacy, who discussed the company's role in supporting independent pharmacies.
UnitedHealth reportedly buys Genoa Healthcare from Advent

UnitedHealth Group has reportedly purchased pharmacy company Genoa Healthcare from Advent International for about $2.5 billion.
Eli Lilly gets FDA green light for Emgality for migraine

Eli Lilly's FDA approval for Emgality is bringing a new preventive treatment of migraine to adults.